SCYNEXIS INC - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by SCYNEXIS, Inc. on February 6, 2017, reporting events that occurred on January 31, 2017. The filing details compensation actions approved by the Board of Directors for the company's executive officers.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation adjustments.
Material Changes and Compensation Actions
The Board approved the following compensation changes for three executive officers:
- 2016 Cash Bonuses: Bonuses were approved based on 2016 performance.
- Marco Taglietti, M.D. (CEO): $210,100
- David Angulo, M.D. (CMO): $136,600
- Eric Francois (CFO): $113,000
- 2017 Base Salaries: New salaries effective March 1, 2017.
- Marco Taglietti, M.D. (CEO): $510,000
- David Angulo, M.D. (CMO): $413,800
- Eric Francois (CFO): $360,500
- Stock Option Grants: Grants under the 2014 Equity Incentive Plan with an exercise price of $3.02 per share, vesting monthly over four years.
- Marco Taglietti, M.D. (CEO): 360,000 shares
- David Angulo, M.D. (CMO): 140,000 shares
- Eric Francois (CFO): 100,000 shares
Guidance, Outlook, and Risks
The filing text does not provide financial guidance, outlook, management commentary on business strategy, or specific risk factors beyond the standard vesting conditions for the stock options.
Investor Verification Checklist
- Verify the total cash bonus payout of $459,700 to the three named officers.
- Confirm the effective date of the new salary structure (March 1, 2017).
- Review the 2014 Equity Incentive Plan terms to understand the full dilution impact of the 600,000 new options granted.
- Check the company's cash position to ensure liquidity is sufficient to cover the immediate bonus payments.